A unique shareholding structure

Pierre Fabre Laboratories has a unique shareholding structure that sets it apart: its only shareholders are the Foundation of the same name - a government-recognized public-interest foundation - and its employees, with the Foundation owning by far the largest stake (86.3%). That original model guarantees the company’s independence and fosters a long-term approach, for the benefit of patients, employees, and all stakeholders. Further, the dividends paid out by the company are used to finance the humanitarian projects run by Fondation Pierre Fabre.

86.3%

Fondation
Pierre Fabre

9.8%

Employee
stock ownership

3.9%

Treasury stock

Updated in March 2026

Employees own 9.8% of the share capital through an employee stock ownership scheme called Ruscus. The scheme, which started in France in 2005 and now includes fourteen other countries, gives employees the chance to acquire a stake in the company’s growth and share in its success. 81% of eligible employees are shareholders, proof of their confidence in the strategy and success of Pierre Fabre Laboratories.

Employee stock ownership is a way of ensuring that the value created by each person’s hard work is fairly distributed. The fact that so many company employees have joined the Ruscus scheme illustrates their confidence in the company’s governance and strategy. 

Maud Vimeux

Human Resources Director

Governance bodies

The Foundation delegates management of Pierre Fabre Laboratories to Pierre Fabre Participations, a controlling company chaired by Pierre-Yves Revol, which has a six-member Supervisory Board. Pierre Fabre Participations appoints the company's main directors and approves its strategy, while safeguarding the humanist values handed down by its founder.

Pierre Yves Revol, Chair of Pierre Fabre Participations

Pierre Fabre Participations ensures the company stays true to its guiding principles:

• Guarantee long-term independence;
• Combine the pharmaceuticals and dermo-cosmetics businesses;
• Invest in research and innovation; 
• Create lasting value rather than short-term profit; 
• Keep its regional roots and civic culture; 
• Support the growth of Fondation Pierre Fabre by paying dividends to the foundation.

Members of the Pierre Fabre S.A. Supervisory Board:

Hervé HOPPENOT

Chair of the Pierre Fabre SA Supervisory Board

Roch DOLIVEUX 

Vice Chair of the Supervisory Board of Pierre Fabre SA

Mme Marie-Anne AYMERICH

Director of Pierre Fabre SA

M. Jean-Laurent BONNAFÉ

Director of Pierre Fabre SA

Mme Sophie LE TANNEUR

Director of Pierre Fabre SA

Mme Isabelle GIROLAMI

Director of Pierre Fabre SA

Mme Marie-France MARCHAND-BAYLET

Director of Pierre Fabre SA

Mme Rachel MAROUANI

Director of Pierre Fabre SA

Mme Florence PARLY

Director of Pierre Fabre SA

M. Olivier SADRAN

Director of Pierre Fabre SA

M. Eduardo SANCHIZ

Director of Pierre Fabre SA

M. Alexandre FALCONNIER

Director of Pierre Fabre SA

Mme Claire MEUNIER

Director of Pierre Fabre SA

M. Jean-François COURET

Director of Pierre Fabre SA

The Supervisory Board has formed three committees:

Strategic Committee chaired by Hervé Hoppenot
This committee issues opinions on the company’s strategic priorities and business development policy, put forward to the Supervisory Board by the executive management team. 
Its members are: Marie-Anne Aymerich, Jean-Laurent Bonnafé, Roch Doliveux, Isabelle Girolami, Hervé Hoppenot, Sophie Le Tanneur, Rachel Marouani, Florence Parly, Olivier Sadran and Eduardo Sanchiz.

Appointments and Remuneration Committee chaired by Roch Doliveux 
This committee helps the Board select its members and corporate executives, and issues recommendations on the remuneration of corporate officers. 
Its members are: Roch Doliveux, Hervé Hoppenot and Pierre-Yves Revol.

Audit and Accounts Committee chaired by Isabelle Girolami 
This committee is in charge of examining the accounts and monitoring issues related to the generation and control of accounting and financial information. It is also responsible for checking the effectiveness of the company’s internal control and risk management systems. 
Its members are: Isabelle Girolami, Eduardo Sanchiz and Jean-François Couret (chair of the employee shareholder scheme).

Executive Committee

Éric DUCOURNAU

CEO of Laboratoires Pierre Fabre

Marie Andrée GAMACHE

CEO of Pierre Fabre Pharma

Venaïg SOLINHAC

CEO Dermo-Cosmetics and Personal Care

Fernando JUNOY

International Director

Éric GOUY

Chief Finance and Legal Affairs Officer

Maud VIMEUX

Human Resources Director